Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care

https://doi.org/10.1016/0895-4356(94)00106-ZGet rights and content

Abstract

Cumulative meta-analysis of clinical trials (a Bayesian interpretation for accumulating evidence) will profoundly affect medical care by summarizing evidence in the assessment of technology innovations. Application of the technique to the randomized control trials (RCTs) of streptokinase treatment of acute myocardial infarction, reduction of peri-operative mortality by antibiotic prophylaxis, and prevention of death from bleeding peptic ulcers has revealed efficacy years before it was suspected by any other means. Arrangement of the trials according to event rate in the controls, effect sizes, quality of the trials or according to covariables of interest has supplied unique information. If carried out prospectively the technique supplies invaluable information regarding indications for another trial, the number of patients necessary to determine the validity of past trends, and the type of patients who might be benefitted. Careful examination in a cumulative manner of the prior trials can reduce the need for future large trials.

References (40)

  • ML Baum et al.

    A survey of clinical trials of antibiotic prophylaxis in colon surgery: evidence against further use of no-treatment controls

    New Engl J Med

    (1981)
  • TC Chalmers et al.

    Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction

    N Engl J Med

    (1977)
  • AG Turpie et al.

    Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction

    N Engl J Med

    (1989)
  • EM Antman et al.

    A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatment for myocardial infarction

    JAMA

    (1992)
  • J Cortadellas et al.

    Estreptocinasa intravenosa en el infarto agudo de miocardio. Reduccion de la mortalidad precoz intrahospitalaria

    Rev Esp Cardiol

    (1989)
  • L Grips et al.

    Late streptokinase infusion and antithrombotic treatment in myocardial infarction reduce subsequent myocardial ischemia

    Am Heart J

    (1991)
  • Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicentrico Estreptoquinasa Republicas de America del Sur) Collaborative Group

    Lancet

    (1992)
  • MJ Stampfer et al.

    Effect of intravenous streptokinase on acute myocardial infarction: pooled results from randomised trials

    N Engl J Med

    (1982)
  • Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto (GISSI)

    Lancet

    (1986)
  • Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group

    Lancet

    (1988)
  • Cited by (0)

    View full text